EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kidney Transplantation in Patients with Fabry Disease—A Case Series from a Single Romanian Center

Elena-Emanuela Rusu, Teodor Căluşi, Bogdan Marian Sorohan, Dorina-Beatrice Tacu, Corina Țincu, Ruxandra-Oana Jurcuț, Robert Adam, Adriana Mursă, Diana-Silvia Zilişteanu, Bogdan Stănciulescu, Sonia Bălănică, Bogdan Obrişcă und 9 weitere

Journal of Clinical Medicine · 14.11.2026 · 15 (22) · 8919

DOI: 10.3390/jcm15228919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.11.2026. Verfasst von Elena-Emanuela Rusu und 20 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Fabry disease (FD) is a rare, X-linked, lysosomal storage multisystemic disorder that may lead to kidney failure, making kidney transplantation (KT) necessary. Data on long-term kidney allograft outcomes and the evolution of systemic FD under disease-specific therapy after KT remain limited.

Methods

We retrospectively evaluated six kidney transplant recipients (KTRs) with FD, who were followed in our center for a median time of 7 years after KT (range, 4–13).

Results

Of these, five patients (83.3%) were male and five had a classic Fabry phenotype. At the last follow-up appointment, patient survival was 100% and five out of six KTRs had a functional kidney graft; the median change in the estimated glomerular filtration rate from 1 year to the last follow-up was +3.3 mL/min/1.73 m2 (range, −50.7 to +10.5). Proteinuria remained low. One patient developed late antibody-mediated rejection with de novo donor-specific antibodies and graft loss at 8 years post-transplantation. Five KTRs were receiving enzyme replacement therapy at the time of KT. Three patients were subsequently switched to migalastat and two later returned to enzyme replacement therapy. Lyso-Gb3 and cardiac structural parameters showed heterogenous longitudinal trajectories, although kidney graft function was generally preserved. No cardiovascular events occurred during follow-up.

Conclusions

These findings indicate that KT is an effective renal replacement therapy in FD and highlight the need for continuous Fabry-specific treatment and multidisciplinary surveillance post-transplantation.

Zitieren

APA

Rusu, E., Căluşi, T., Sorohan, B. M., Tacu, D., Țincu, C., Jurcuț, R., Adam, R., Mursă, A., Zilişteanu, D., Stănciulescu, B., Bălănică, S., Obrişcă, B., Ştefănescu, V., Mureşan, F., Gherghiceanu, M., Bucşa, C., Vizireanu, P., Baston, C., Gîngu, C., …, & Ismail, G. (2026). Kidney Transplantation in Patients with Fabry Disease—A Case Series from a Single Romanian Center. Journal of Clinical Medicine, 15(22), 8919. https://doi.org/10.3390/jcm15228919

Vancouver

Rusu E, Căluşi T, Sorohan BM, Tacu D, Țincu C, Jurcuț R, et al. Kidney Transplantation in Patients with Fabry Disease—A Case Series from a Single Romanian Center. Journal of Clinical Medicine. 2026;15(22):8919. doi:10.3390/jcm15228919

BibTeX
@article{Rusu2026,
  author = {Rusu, Elena-Emanuela and Căluşi, Teodor and Sorohan, Bogdan Marian and Tacu, Dorina-Beatrice and Țincu, Corina and Jurcuț, Ruxandra-Oana and Adam, Robert and Mursă, Adriana and Zilişteanu, Diana-Silvia and Stănciulescu, Bogdan and Bălănică, Sonia and Obrişcă, Bogdan and Ştefănescu, Vlad and Mureşan, Filip and Gherghiceanu, Mihaela and Bucşa, Cristina and Vizireanu, Paula and Baston, Cătălin and Gîngu, Constantin and Guler-Margaritis, Silviu and Ismail, Gener},
  title = {Kidney Transplantation in Patients with Fabry Disease—A Case Series from a Single Romanian Center},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {8919},
  doi = {10.3390/jcm15228919}
}
Kostenlos starten →